Prostate Cancer Pipeline Insights: Comprehensive Analysis of Key Emerging Therapies and Pharmaceutical Companies

23 Mar 2021
www.globenewswire.com
Small molecular drug
Los Angeles, USA, March 22, 2021 (GLOBE NEWSWIRE) -- Prostate Cancer Pipeline Insights: Comprehensive Analysis of Key Emerging Therapies and Pharmaceutical Companies With over 900 key pharmaceutical companies working, the Prostate cancer pipeline projects a robust and promising picture in near future, says DelveInsight DelveInsight’s ‘Prostate Cancer Pipeline Insights’ report highlights major breakthroughs happening in the domain, emerging therapies in different stages of clinical development, segmented based on MoA, RoA, molecule types, drug delivery platform, and so on. Some of the key highlights from the Prostate Cancer Drug Pipeline report: Request for Sample @ Prostate Cancer Therapeutic Assessment Prostate cancer originates from the prostate gland located in the pelvis, next to the bladder, of men. It is the second-leading cause of death due to cancers in men in the U.S. About 1 in 9 men are diagnosed with prostate cancer in their lifetime. Growths in the prostate can be benign (not cancer) or malignant (cancer). Prostate Cancer Drug Profiles Tomivosertib: Effector TherapeuticsTomivosertib (also known as eFT508) is a novel, potent and highly selective oral small molecule inhibitor of mitogen-activated protein kinase interacting kinases 1 and 2, or collectively, MNK1/2.  MNK1/2 plays a crucial role in the development of many tumors, including by controlling in a coordinated manner the expression of multiple factors that attenuate an immune response. Tomivosertib is currently in the Phase II stage of development. This Phase 2 study examines the efficacy, safety, tolerability, and pharmacokinetics (PK) of eFT508 (tomivosertib) in metastatic castration-resistant prostate cancer patients who have documented PSAPSA progression on treatment with one of three hormone therapies – abiraterone, enzalutamide or apalutamide and for whom no curative therapy exists. The primary objective of this study is to assess the anti-tumor response to eFT508 (tomivosertib) in mCRPC. Gain more rich insights into drug profiles, trials, stages @ Prostate cancer drug pipeline Prostate Cancer Emerging Drugs Profile at a Glance Prostate Cancer Therapeutic Assessment By Product Type By Stage By Route of Administration By Molecule Type By Mechanism of Action By Targets By Stage and Molecule TypeBy Stage and Route of AdministrationBy Stage and Product Type Get a holistic view of the pipeline analysis @ Prostate Cancer Drug Pipeline and Emerging Trends Scope of the Report Coverage: GlobalKey Players: Pfizer, Myovant Biosciences, Effector Therapeutics, Mediolanum, Merck, ESSA Pharma, Sanofi, Astellas Pharma, AstraZeneca, Bayer, Janssen research & development LLC, Bristol Myers Squibb, Eli Lilly and Company, Amgen, POINT Biopharma, Hinnova Pharmaceuticals, Sophiris Bio, Ultimovacs, Foresee Pharmaceuticals, Luye Pharma Group, Abbott, AB science, Ferring pharmaceuticals, Jiangsu HengRui Medicine, Hoffmann-La Roche, Novartis, Celgene, Endocyte, Millennium Pharmaceuticals, Medivation, Veru, Progenics Pharmaceuticals, Boehringer Ingelheim, US Biotest, Antev, Elevation oncology, Abgenix, Astellas Pharma, Orion Pharma, Clovis Oncology, Exelixis, Takeda, Novus Therapeutics, Candel Therapeutics, Ipsen, MEI Pharma, Aragon Pharmaceuticals, MedImmune,  CytRx, Tmunity Therapeutics, Inovio Pharmaceuticals, Forma Therapeutics, Luye Pharma, Health Ever Bio-Tech, Advaxis, Corcept Therapeutics, and several others. Key Questions Answered Got queries? Get answers @ Prostate Cancer Emerging Therapies Table of Contents Reach out for a live demo of the report @ Prostate Cancer Pipeline Insights Related Reports Prostate Cancer MarketDelveInsight's "Prostate cancer Market Insights, Epidemiology, and Market Forecast-2030" report. Cervical Cancer MarketDelveInsight’s ‘Cervical Cancer –Market Insights, Epidemiology, and Market Forecast-2030’ report. Multiple Myeloma MarketDelveInsight’s ‘Multiple Myeloma (MM)-Market Insights, Epidemiology and Market Forecast—2030’ report. Acral Lentiginous Melanoma MarketDelveInsight's "Acral lentiginous melanoma Market Insights, Epidemiology, and Market Forecast-2030" report. Acute Lymphoblastic Leukemia MarketDelveInsight's "Acute Lymphoblastic Leukemia Market Insights, Epidemiology, and Market Forecast-2030" report. Acute Myeloid Leukemia MarketDelveInsight's "Acute Myeloid Leukemia (AML) Market Insights, Epidemiology, and Market Forecast-2030" report. Adenoid Cystic Carcinoma MarketDelveInsight's "Adenoid Cystic Carcinoma Market Insights, Epidemiology, and Market Forecast-2030" report. Adult T Cell Leukemia Lymphoma MarketDelveInsight's "Adult T-Cell Leukemia-Lymphoma - Market Insights, Epidemiology, and Market Forecast-2030" report. Advanced Liver Cancer MarketDelveInsight's "Advanced Liver Cancer - Market Insights, Epidemiology, and Market Forecast-2030" report. Advanced Melanoma MarketDelveInsight's "Advanced Melanoma - Market Insights, Epidemiology, and Market Forecast-2030" report. Advanced Pancreatic Cancer MarketDelveInsight's "Advanced Pancreatic Cancer - Market Insights, Epidemiology, and Market Forecast-2030" report. Advanced Recurrent Ovarian Cancer MarketDelveInsight's "Advanced Recurrent Ovarian Cancer - Market Insights, Epidemiology, and Market Forecast-2030" report. AIDS-Related Kaposi’s Sarcoma MarketDelveInsight's "AIDS-Related Kaposi's Sarcoma - Market Insights, Epidemiology, and Market Forecast-2030" report. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Organizations
Indications
Targets
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.